 | • レポートコード：MRC2312MG02890 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のHER2標的薬市場規模と予測を収録しています。・世界のHER2標的薬市場：売上、2018年-2023年、2024年-2029年 ・世界のHER2標的薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のHER2標的薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「モノクローナル抗体」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 HER2標的薬のグローバル主要企業は、Roche、 GSK、 Boehringer Digelheim、 Pfizer、 AstraZeneca、 Seagen、 MacroGenics、 Takeda、 Daiichi Sankyo、 Novartis AG、 RemeGen、 Sunshine Guojian、 Hengrui Medicineなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、HER2標的薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のHER2標的薬市場：タイプ別、2018年-2023年、2024年-2029年 世界のHER2標的薬市場：タイプ別市場シェア、2022年 ・モノクローナル抗体、低分子化合物、抗体薬物複合体 世界のHER2標的薬市場：用途別、2018年-2023年、2024年-2029年 世界のHER2標的薬市場：用途別市場シェア、2022年 ・乳がん、大腸がん、胃がん、その他 世界のHER2標的薬市場：地域・国別、2018年-2023年、2024年-2029年 世界のHER2標的薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるHER2標的薬のグローバル売上、2018年-2023年 ・主要企業におけるHER2標的薬のグローバル売上シェア、2022年 ・主要企業におけるHER2標的薬のグローバル販売量、2018年-2023年 ・主要企業におけるHER2標的薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Roche、 GSK、 Boehringer Digelheim、 Pfizer、 AstraZeneca、 Seagen、 MacroGenics、 Takeda、 Daiichi Sankyo、 Novartis AG、 RemeGen、 Sunshine Guojian、 Hengrui Medicine ************************************************************* ・調査・分析レポートの概要 HER2標的薬市場の定義 市場セグメント 世界のHER2標的薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のHER2標的薬市場規模 世界のHER2標的薬市場規模：2022年 VS 2029年 世界のHER2標的薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのHER2標的薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のHER2標的薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：モノクローナル抗体、低分子化合物、抗体薬物複合体 HER2標的薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：乳がん、大腸がん、胃がん、その他 HER2標的薬の用途別グローバル売上・予測 ・地域別市場分析 地域別HER2標的薬市場規模 2022年と2029年 地域別HER2標的薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Roche、 GSK、 Boehringer Digelheim、 Pfizer、 AstraZeneca、 Seagen、 MacroGenics、 Takeda、 Daiichi Sankyo、 Novartis AG、 RemeGen、 Sunshine Guojian、 Hengrui Medicine ... |
This research report provides a comprehensive analysis of the HER2 Target Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global HER2 Target Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of HER2 Target Drugs, challenges faced by the industry, and potential opportunities for market players.
The global HER2 Target Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The HER2 Target Drugs market presents opportunities for various stakeholders, including Breast Cancer, Colorectal Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in HER2 Target Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global HER2 Target Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the HER2 Target Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the HER2 Target Drugs market.
Market Overview: The report provides a comprehensive overview of the HER2 Target Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monoclonal Antibodies, Small Molecule Chemicals), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the HER2 Target Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the HER2 Target Drugs market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the HER2 Target Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the HER2 Target Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the HER2 Target Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the HER2 Target Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for HER2 Target Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the HER2 Target Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
HER2 Target Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Monoclonal Antibodies
Small Molecule Chemicals
Antibody Drug Conjugate
Market segment by Application
Breast Cancer
Colorectal Cancer
Stomach Cancer
Other
Global HER2 Target Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Roche
GSK
Boehringer Digelheim
Pfizer
AstraZeneca
Seagen
MacroGenics
Takeda
Daiichi Sankyo
Novartis AG
RemeGen
Sunshine Guojian
Hengrui Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of HER2 Target Drugs, market overview.
Chapter 2: Global HER2 Target Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of HER2 Target Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HER2 Target Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global HER2 Target Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 HER2 Target Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global HER2 Target Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global HER2 Target Drugs Overall Market Size
2.1 Global HER2 Target Drugs Market Size: 2022 VS 2029
2.2 Global HER2 Target Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global HER2 Target Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top HER2 Target Drugs Players in Global Market
3.2 Top Global HER2 Target Drugs Companies Ranked by Revenue
3.3 Global HER2 Target Drugs Revenue by Companies
3.4 Global HER2 Target Drugs Sales by Companies
3.5 Global HER2 Target Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 HER2 Target Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers HER2 Target Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 HER2 Target Drugs Players in Global Market
3.8.1 List of Global Tier 1 HER2 Target Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 HER2 Target Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global HER2 Target Drugs Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Small Molecule Chemicals
4.1.4 Antibody Drug Conjugate
4.2 By Type – Global HER2 Target Drugs Revenue & Forecasts
4.2.1 By Type – Global HER2 Target Drugs Revenue, 2018-2023
4.2.2 By Type – Global HER2 Target Drugs Revenue, 2024-2029
4.2.3 By Type – Global HER2 Target Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global HER2 Target Drugs Sales & Forecasts
4.3.1 By Type – Global HER2 Target Drugs Sales, 2018-2023
4.3.2 By Type – Global HER2 Target Drugs Sales, 2024-2029
4.3.3 By Type – Global HER2 Target Drugs Sales Market Share, 2018-2029
4.4 By Type – Global HER2 Target Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global HER2 Target Drugs Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Colorectal Cancer
5.1.4 Stomach Cancer
5.1.5 Other
5.2 By Application – Global HER2 Target Drugs Revenue & Forecasts
5.2.1 By Application – Global HER2 Target Drugs Revenue, 2018-2023
5.2.2 By Application – Global HER2 Target Drugs Revenue, 2024-2029
5.2.3 By Application – Global HER2 Target Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global HER2 Target Drugs Sales & Forecasts
5.3.1 By Application – Global HER2 Target Drugs Sales, 2018-2023
5.3.2 By Application – Global HER2 Target Drugs Sales, 2024-2029
5.3.3 By Application – Global HER2 Target Drugs Sales Market Share, 2018-2029
5.4 By Application – Global HER2 Target Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global HER2 Target Drugs Market Size, 2022 & 2029
6.2 By Region – Global HER2 Target Drugs Revenue & Forecasts
6.2.1 By Region – Global HER2 Target Drugs Revenue, 2018-2023
6.2.2 By Region – Global HER2 Target Drugs Revenue, 2024-2029
6.2.3 By Region – Global HER2 Target Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global HER2 Target Drugs Sales & Forecasts
6.3.1 By Region – Global HER2 Target Drugs Sales, 2018-2023
6.3.2 By Region – Global HER2 Target Drugs Sales, 2024-2029
6.3.3 By Region – Global HER2 Target Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America HER2 Target Drugs Revenue, 2018-2029
6.4.2 By Country – North America HER2 Target Drugs Sales, 2018-2029
6.4.3 US HER2 Target Drugs Market Size, 2018-2029
6.4.4 Canada HER2 Target Drugs Market Size, 2018-2029
6.4.5 Mexico HER2 Target Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe HER2 Target Drugs Revenue, 2018-2029
6.5.2 By Country – Europe HER2 Target Drugs Sales, 2018-2029
6.5.3 Germany HER2 Target Drugs Market Size, 2018-2029
6.5.4 France HER2 Target Drugs Market Size, 2018-2029
6.5.5 U.K. HER2 Target Drugs Market Size, 2018-2029
6.5.6 Italy HER2 Target Drugs Market Size, 2018-2029
6.5.7 Russia HER2 Target Drugs Market Size, 2018-2029
6.5.8 Nordic Countries HER2 Target Drugs Market Size, 2018-2029
6.5.9 Benelux HER2 Target Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia HER2 Target Drugs Revenue, 2018-2029
6.6.2 By Region – Asia HER2 Target Drugs Sales, 2018-2029
6.6.3 China HER2 Target Drugs Market Size, 2018-2029
6.6.4 Japan HER2 Target Drugs Market Size, 2018-2029
6.6.5 South Korea HER2 Target Drugs Market Size, 2018-2029
6.6.6 Southeast Asia HER2 Target Drugs Market Size, 2018-2029
6.6.7 India HER2 Target Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America HER2 Target Drugs Revenue, 2018-2029
6.7.2 By Country – South America HER2 Target Drugs Sales, 2018-2029
6.7.3 Brazil HER2 Target Drugs Market Size, 2018-2029
6.7.4 Argentina HER2 Target Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa HER2 Target Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa HER2 Target Drugs Sales, 2018-2029
6.8.3 Turkey HER2 Target Drugs Market Size, 2018-2029
6.8.4 Israel HER2 Target Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia HER2 Target Drugs Market Size, 2018-2029
6.8.6 UAE HER2 Target Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche HER2 Target Drugs Major Product Offerings
7.1.4 Roche HER2 Target Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK HER2 Target Drugs Major Product Offerings
7.2.4 GSK HER2 Target Drugs Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Boehringer Digelheim
7.3.1 Boehringer Digelheim Company Summary
7.3.2 Boehringer Digelheim Business Overview
7.3.3 Boehringer Digelheim HER2 Target Drugs Major Product Offerings
7.3.4 Boehringer Digelheim HER2 Target Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Boehringer Digelheim Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer HER2 Target Drugs Major Product Offerings
7.4.4 Pfizer HER2 Target Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca HER2 Target Drugs Major Product Offerings
7.5.4 AstraZeneca HER2 Target Drugs Sales and Revenue in Global (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Seagen
7.6.1 Seagen Company Summary
7.6.2 Seagen Business Overview
7.6.3 Seagen HER2 Target Drugs Major Product Offerings
7.6.4 Seagen HER2 Target Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Seagen Key News & Latest Developments
7.7 MacroGenics
7.7.1 MacroGenics Company Summary
7.7.2 MacroGenics Business Overview
7.7.3 MacroGenics HER2 Target Drugs Major Product Offerings
7.7.4 MacroGenics HER2 Target Drugs Sales and Revenue in Global (2018-2023)
7.7.5 MacroGenics Key News & Latest Developments
7.8 Takeda
7.8.1 Takeda Company Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda HER2 Target Drugs Major Product Offerings
7.8.4 Takeda HER2 Target Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Takeda Key News & Latest Developments
7.9 Daiichi Sankyo
7.9.1 Daiichi Sankyo Company Summary
7.9.2 Daiichi Sankyo Business Overview
7.9.3 Daiichi Sankyo HER2 Target Drugs Major Product Offerings
7.9.4 Daiichi Sankyo HER2 Target Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Daiichi Sankyo Key News & Latest Developments
7.10 Novartis AG
7.10.1 Novartis AG Company Summary
7.10.2 Novartis AG Business Overview
7.10.3 Novartis AG HER2 Target Drugs Major Product Offerings
7.10.4 Novartis AG HER2 Target Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Novartis AG Key News & Latest Developments
7.11 RemeGen
7.11.1 RemeGen Company Summary
7.11.2 RemeGen Business Overview
7.11.3 RemeGen HER2 Target Drugs Major Product Offerings
7.11.4 RemeGen HER2 Target Drugs Sales and Revenue in Global (2018-2023)
7.11.5 RemeGen Key News & Latest Developments
7.12 Sunshine Guojian
7.12.1 Sunshine Guojian Company Summary
7.12.2 Sunshine Guojian Business Overview
7.12.3 Sunshine Guojian HER2 Target Drugs Major Product Offerings
7.12.4 Sunshine Guojian HER2 Target Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Sunshine Guojian Key News & Latest Developments
7.13 Hengrui Medicine
7.13.1 Hengrui Medicine Company Summary
7.13.2 Hengrui Medicine Business Overview
7.13.3 Hengrui Medicine HER2 Target Drugs Major Product Offerings
7.13.4 Hengrui Medicine HER2 Target Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Hengrui Medicine Key News & Latest Developments
8 Global HER2 Target Drugs Production Capacity, Analysis
8.1 Global HER2 Target Drugs Production Capacity, 2018-2029
8.2 HER2 Target Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global HER2 Target Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HER2 Target Drugs Supply Chain Analysis
10.1 HER2 Target Drugs Industry Value Chain
10.2 HER2 Target Drugs Upstream Market
10.3 HER2 Target Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 HER2 Target Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
